Orchid Cellmark's IPO

Orchid Cellmark raised a round of funding on June 14, 2001. Investors include Public.

Orchid Cellmark is a Healthcare/Biotechnology company based in Princeton, New Jersey. Orchid Cellmark's investors include Symmetry Capital Management, Mainfield Enterprises, SF Capital Partners, UBS, …

Articles about Orchid Cellmark's IPO: